Company Filing History:
Years Active: 2017
Title: Innovations of Shao-Wen Hung in Cancer Research
Introduction
Shao-Wen Hung is a notable inventor based in Pingtung County, Taiwan. He has made significant contributions to the field of cancer research, particularly in the area of cancer metastasis. His innovative work focuses on methods to suppress the spread of cancer cells, which is a critical challenge in cancer treatment.
Latest Patents
Shao-Wen Hung holds a patent for the "Suppression of cancer metastasis." This patent outlines methods of using fibrillar proteins to inhibit cancer metastasis. Cancer metastasis is recognized as the most common cause of treatment failure and death among cancer patients. His research demonstrates that tumor cell invasion and migration can be significantly inhibited after treatment with fibrillar proteins, such as rVP1, F-HSA, and F-BSA, in vitro. Furthermore, rVP1 has shown the ability to significantly suppress murine and human breast cancer metastasis, as well as human prostate and ovarian cancer metastasis in vivo. Additionally, F-HSA has been found to significantly suppress murine breast cancer metastasis.
Career Highlights
Shao-Wen Hung is affiliated with Academia Sinica, where he conducts his research and develops his innovative methods. His work has garnered attention for its potential impact on cancer treatment and patient outcomes.
Collaborations
Shao-Wen Hung collaborates with esteemed colleagues, including Shu-Mei Liang and Ching-Feng Chiu, who contribute to his research efforts and advancements in cancer metastasis suppression.
Conclusion
Shao-Wen Hung's innovative research and patent on the suppression of cancer metastasis highlight his commitment to improving cancer treatment. His work has the potential to significantly enhance the effectiveness of therapies for cancer patients.